Jeremiah Helm Quoted by Media on Upcoming Supreme Court “Skinny Label” Case Arguments
Knobbe Martens partner Jeremiah Helm shared his insights with Law360 and MLex on the key issues in the Supreme Court case Hikma v. Amarin ahead of oral arguments this week....
Knobbe Martens’ Litigation Practice, Partner Brian Horne Named Finalists at The Recorder’s California Legal Awards
Firm named a finalist for Tech Industry Litigation Department of the Year, Mr. Horne among Intellectual Property Lawyer of the Year finalists IRVINE, Calif., April 28, 2026 – Knobbe Martens...
Factual Stipulations May Simplify Discovery, but Also Help Plaintiff Navigate Difficult Issues of Fact and Law
VLSI TECHNOLOGY LLC v. INTEL CORP. Before Moore, Chen, and Kleeh. Appeal from the United States District Court for the Northern District of California. Summary: The Federal Circuit reversed summary...
Implant Trade Secrets Are Not Protectable Due to Disclosure in Patents
INTERNATIONAL MEDICAL DEVICES, INC. v. CORNELL Before Dyk, Reyna, and Taranto. Appeal from the United States District Court for the Central District of California Summary: The Federal Circuit held under...
AI Is Going Nuclear: How Major Tech Companies Are Pursuing Nuclear Energy—And How Energy Startups Can Avoid Common Collaboration Pitfalls
Key Takeaways: As major technology companies turn to nuclear energy, early-stage nuclear companies may face heightened intellectual property (IP) risks due to asymmetric negotiations. Building and documenting strong background IP—and...
Knobbe Martens Again Named Among Leading Fashion Law Firms by The Fashion Law
IRVINE, Calif., April 23, 2026 – Highlighting the firm’s extensive experience in IP protection and enforcement for some of the world’s most well-known fashion brands, Knobbe Martens has once again...
Tom Cowan Discusses IP Issues Relevant to “Dual-Use” Aerospace Technologies on The Space Hour Podcast
In a recent episode of The Space Hour podcast, Knobbe Martens partner Tom Cowan offered insights on the unique intellectual property (IP) challenges facing “dual-use” aerospace companies – those technology...
U.S. Issues Guidance for American Space Nuclear Power Initiative
Key Takeaways: A recently issued U.S. National Initiative encourages collaboration between the federal government and the private sector to accelerate the development and deployment of space-based nuclear power systems. Private...
Thaler v. Perlmutter: Human Authorship Remains a Cornerstone Requirement for Copyright Registration
Key Takeaway: The Supreme Court denied certiorari of the D.C. Circuit’s holding that works created entirely by autonomous AI systems are categorically ineligible for copyright under the Copyright Act. Thus, even...
Jonathan Menkes Offers Insights in Law360 on Lion King Defamation Suit and Public Commenting Risks
In the Law360 article “’Lion King’ Suit May Not Reign In Podcasting Legal Jungle,” Knobbe Martens Trademark and Brand Protection partner Jonathan Menkes shared insights on the legal foundations of...
Three Knobbe Martens Partners Named Los Angeles Times “Life Sciences Visionaries”
IRVINE, Calif., April 20, 2026 – Knobbe Martens is pleased to share that partners Salima Merani, Ph.D., Jason Jardine, and Kimberly Miller, Ph.D. have been recognized as “Life Sciences Visionaries”...
Well-Known Genus, Novel Method: A Post-Amgen Framework for Written Description & Enablement
Key Takeaways: Recent Federal Circuit decision draws a meaningful distinction between patents that claim a broad genus as the invention itself and those that claim a novel therapeutic method using...
FDA Issues Recommendations for the Development of Individualized Therapies for Patients With Ultra-Rare Diseases
Key Takeaway: The FDA is developing a “plausible mechanism framework” to facilitate approval of individualized therapies for the treatment of rare genetic diseases that currently face approval challenges. As discussed previously...
No Do-Overs: Voluntary Dismissal Does Not Reset Deadline for Stay
ASCENDIS PHARMA A/S v. BIOMARIN PHARMACEUTICAL INC. Before Lourie, Chen, and Stoll. Appeal from the United States District Court for the Northern District of California. Summary: A respondent in an...
Standing Still? Only if Injury-In-Fact Is Tied to the Claims at Issue
IRONSOURCE LTD. v. DIGITAL TURBINE, INC. Before Moore, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: An appellant seeking to establish Article III standing based on...
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA. Transseptal puncture is designed to enable access to...
Veteran Ventures Capital Announces Investment in Hybron Technologies as Hybron Technologies Closes $25M Seed Round
Key Takeaways: Hybron Technologies, a U.S. based Manufacturing company focused on lightweight composites for aerospace and defense applications, closes an oversubscribed $25M seed round. The increased need for domestic production...
IP Implications of NRC’s Proposed New Fast Lane for Licensing Reactor Designs Previously Approved by DOE or DOD
Key Takeaway: The NRC’s proposed streamlined DOE/DOD reactor licensing pathway includes public disclosure obligations that can constitute prior art to later filed patent applications, and that raise potential inventorship issues,...
Federal Circuit Review | March 2026
March Federal Circuit Newsletter (Japanese) March Federal Circuit Newsletter (Chinese) Software Claims Failed Alice Step One Where Purported Improvements Were Not Claimed In Trustees Of Columbia University v. Gen Digital...
PTAB Update | March 2026
PTAB to Rehear Ex Parte Baurin: Revisiting the Interplay of Obviousness-Type Double Patenting and Patent Term Adjustment After Cellect and Allergan Daniel M. Mittelstein & Michael L. Fuller The PTO...
Alistair McIntyre and Tom Cowan Explore Latest Section 101 Patent Eligibility Developments in Inventors Digest Article
In their recent Inventors Digest article, Knobbe Martens lawyers Alistair McIntyre and Tom Cowan examine key developments in Section 101 patent eligibility, and offer practical guidance for inventors navigating complex...
